|
2,088
|
| 16842 |
Advanced glycation end-product
|
|
increases_expression of
|
F3
|
|
|
10082470
|
Diabetes mellitus, type II
Insulin resistance
|
|
2,104
|
| 17867 |
Major depressive disorder
|
|
increases_quantity of
|
F3
|
|
|
20161799
|
Major depressive disorder
|
|
6,712
|
| 64839 |
F3
|
|
is_part_of
|
Coagulation factor VIIa - tissue factor complex
|
after vascular injury
|
|
|
Factor X deficiency
|
|
6,747
|
| 65371 |
EGR1
|
|
increases_activity of
|
F3
|
|
|
27230643
|
Diabetes mellitus, type II
Insulin resistance
Cardiomyopathy, diabetic
|
|
6,772
|
| 65764 |
F7
|
|
interacts (colocalizes) with
|
F3
|
to induce blood coagulation
|
|
10692465
|
Metabolic
|
|
6,790
|
| 65939 |
F3
|
|
interacts (colocalizes) with
|
F7
|
|
| 65940 |
F3
|
|
increases_activity of
|
F9
|
|
| 65941 |
F3
|
|
increases_activity of
|
F10
|
|
| 65942 |
F3
|
|
increases_quantity of
|
Thrombin
|
|
| 65964 |
F3
|
|
is localized in
|
atherosclerotic lesions
|
|
| 65966 |
alternative mRNA splicing, via spliceosome
|
|
affects_activity of
|
F3
|
|
|
12652293
|
Metabolic
|
|
7,492
|
| 73893 |
Diabetes mellitus, type II
|
|
increases_quantity of
|
F3
|
in blood, in platelet microparticles
|
|
27173919
|
Diabetes mellitus, type II
Insulin resistance
Atherosclerosis
|
|
7,879
|
| 78570 |
Terminal complement C5b-9 complex
|
|
increases_expression of
|
F3
|
|
|
26091721
|
Immunological
Atherosclerosis
|
|
9,657
|
| 101835 |
DROSHA
|
|
decreases_expression of
|
F3
|
F3 mRNA is upregulated in Drosha depleted HepG2 cells compared with control transfected cells
|
|
18701644
|
Metabolic
|
|
12,080
|
| 118711 |
monocyte
|
|
increases_quantity of
|
F3
|
during inflammation
|
| 118712 |
macrophage
|
|
increases_quantity of
|
F3
|
during inflammation
|
|
32348783
|
Cardiovascular disease
COVID-19
|
|
12,082
|
| 118688 |
Angiotensin II
|
|
increases_expression of
|
F3
|
in endothelial cells; via AGTR1
|
| 118690 |
AGTR1
|
|
increases_expression of
|
F3
|
in endothelial cells
|
|
32348783
|
Cardiovascular disease
COVID-19
|
|
12,083
|
| 118733 |
acute respiratory distress syndrome
|
|
increases_quantity of
|
F3
|
in plasma
|
|
32348783
|
Cardiovascular disease
COVID-19
|
|
12,097
|
| 118799 |
IL6
|
|
increases_expression of
|
F3
|
in monocytes
|
| 118830 |
IL6
|
|
increases_quantity of
|
F3
|
in monocytes
|
| 118831 |
CXCL8
|
|
increases_expression of
|
F3
|
in monocytes
|
| 118832 |
CXCL8
|
|
increases_quantity of
|
F3
|
in monocytes
|
|
9437185
|
Inflammation
|
|
12,103
|
| 118841 |
IL6
|
|
increases_expression of
|
F3
|
in aortic endothelial cell
|
| 118843 |
IL1B
|
|
increases_expression of
|
F3
|
in aortic endothelial cell
|
| 118844 |
TNF
|
|
increases_expression of
|
F3
|
in aortic endothelial cell
|
|
28303603
|
Inflammation
|
|
13,337
|
| 125879 |
SARS-CoV-2 infection
|
|
affects_expression of
|
F3
|
|
|
|
COVID-19
|
CIDeRplus